Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 7, 2003, Pages 423-429

  Menges, Markus ^a   Schmidt, Carsten ^a   Lindemann, Werner ^a   Ridwelski, Karsten ^b,c   Pueschel, Werner ^a   Jüngling, Bernhard ^a   Feifel, Gernot ^a   Schilling, Martin ^a   Stallmach, Andreas ^a   Zeitz, Martin ^a,d  

^a SAARLAND UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Municipal Hospital   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Adverse effects; Antineoplastic combined chemotherapy protocols; Drug therapy; Locally advanced gastric cancer; Neoadjuvant therapy; Stomach neoplasms; Surgery

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; PLATINUM;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURGERY; CLINICAL ARTICLE; CYTOTOXICITY; DIARRHEA; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; LAPAROTOMY; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SIDE EFFECT; STOMACH CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; LEUCOVORIN; NEOADJUVANT THERAPY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0037886119     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0467-1     Document Type: Article

References (29)

1. Cascinu S, Labianca R, Graziano F, Pancera G, Barni S, Frontini L, Luporini G, Cellerino R, Catalano G (1998) Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer 78:390-393
2. Crookes P, Leichman CG, Leichman L, Tan M, Laine L, Stain S, Baranda J, Casagrande Y, Groshen S, Silberman H (1997) Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer 79:1767-1775
3. Fink U, Schumacher C, Böttcher K(1993) Neoadjuvant chemotherapy with etoposide/adriamycin and cisplatin (EAP) in locally advanced gastric carcinoma. In: Salmon SE (ed) Adjuvant therapy of cancer, vol. VII. Lippincott, Philadelphia, pp 272-278
4. Fink U, Schuhmacher C, Stein HJ, Busch R, Feussner H, Dittler HJ, Helmberger A, Boettcher K, Siewert JR (1995) Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg 82:1248-1252
5. Furukawa H, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Ohigashi H, Kameyama M, Nkamori S, Yasuda T (1998) A preoperative adjuvant chemotherapy for scirrhous gastric cancer - a phase II study for stage IV cancer. Proc Am Soc Clin Oncol, abstract 1119
6. Gallardo-Rincon D, Onate-Ocana LF, Calderillo-Ruiz G (2000) Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Ann Surg Oncol 7:45-50
7. Hermanek P, Sobin LH (1992) UICC. TNM classification of malignant tumours, 4th edn, 2nd revision. Springer, Berlin Heidelberg New York Tokyo
8. Hermanek P, Henson DE, Hurter RVP, Sobin LH (1993) UICC. TNM supplement. A commentary on uniform use. Springer, Berlin Heidelberg New York Tokyo
9. Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Borer J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M (1996) Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14:1818-1828
10. Leichman L, Silberman H, Leichman CG, Spears CP, Ray M, Muggia FM, Kiyabu M, Radin R, Laine L, Stain S (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol 10:1933-1942
11. Lerner A, Gonin R, Steele GDJ, Mayer RJ (1992) Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol 10:536-540
12. Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA (1999) Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 229:303-308
13. Melcher AA, Mort D, Maughan TS (1996) Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer. Br J Cancer 74:1651-1654
14. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
15. Plukker JT, Mulder NH, Sleijfer DT, Grond J, Verschueren RC (1991) Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78:955-958
16. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ (1993) Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 72:2089-2097
17. Rougier P, Lasser P, Ducreux M, Mahjoubi M, Bognel C, Elias D (1994) Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol [Suppl] 5:359-368
18. Rougier P, Mahjoubi M, Lasser P, Ducreux M, Oliveira J, Ychou M, Pignon JP, Elias D, Bellefqih S, Bognel C (1994) Neoadjuvant chemotherapy in locally advanced gastric carcinoma - a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. Eur J Cancer 30A:1269-1275
19. Ryan P, McCarthy S, Kelly J, Collins JK, Grogan L, Breathnach O, Shanahan F, Walsh TN, O'Sullivan CO (2002) Bone marrow micrometastases in esophago-gastric cancer: evidence for clearance in patients receiving neoadjuvant chemoradiotherapy (abstract). Proc Am Soc Clin Oncol, abstract 539
20. Schuhmacher CP, Fink U, Becker K, Busch R, Dittler HJ, Mueller J, Siewert JR (2001) Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer 91:918-927
21. Schwartz G, Kelsen D, Christman K (1993) A phase II study of neoadjuvant FAMtx (5-fluorouracil/adriamycin/methotrexate) and postoperative intraperitoneal (i.p.) 5-FU and cisplatin in high-risk patients with gastric cancer (abstract). Proc Am Soc Clin Oncol, abstract 12
22. Siewert JR, Schuhmacher C, Fink U (1998) The German EORTC study of neoadjuvant therapy of stomach carcinoma. Langenbecks Arch Chir Suppl Kongressbd 115:717-719
23. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B, Wils JA (2000) Final results of a randomized phase-III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18:2648-2657
24. Wanebo HJ, Kennedy BJ, Winchesterm DP, Stewart AK, Fremgen AM (1996) Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg 185:177-184
25. Wilke H, Preusser P, Fink U, Gunzer U, Meyer HJ, Meyer J, Siewert JR, Achterrath W, Lenaz L, Knipp H (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7:1318-1326
26. Wilke H, Korn M, Vanhofer U, Fink U, Stahl M, Preusser P, Kohne C, Klassen U, Harstrick A, Schmoll HJ, Seeber S (1996) Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer. J Infus Chemother 6:123-126
27. Wils JA, Klein HO, Wagener DJ, Bleiberg H, Reis H, Korsten F, Conroy T, Fickers M, Leyvraz S, Buyse M (1991) Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 9:827-831
28. Ychou M, Astre C, Rouanet P, Fabre JM, Saint-Aubert B, Domergue J, Ribard D, Ciurana AJ, Janbon C, Pujol H (1996) A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer. Eur J Cancer 32A: 1933-1937
29. Yonemura Y, Sawa T, Kinoshita K, Matsuki N, Fushida S, Tanaka S, Ohoyama S, Takashima T, Kimura H, Kamata T (1993) Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17:256-261